Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Diabetes Mellitus, Insulin-Dependent, 12 × CTLA-4 Antigen × 1 year × Clear all

Sponsor

Conditions

Melanoma 13 Carcinoma, Renal Cell 10 Neoplasm Metastasis 6 Prostatic Neoplasms 5 Carcinoma, Non-Small-Cell Lung 5 Ovarian Neoplasms 4 Myelodysplastic Syndromes 4 Lung Neoplasms 4 Clear-cell metastatic renal cell carcinoma 4 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Leukemia, Myeloid, Acute 3 Carcinoma, Transitional Cell 3 Brain Neoplasms 3 Uveal Melanoma 2 Urogenital Neoplasms 2 Ureteral Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma 2 Rectal Neoplasms 2 Penile Neoplasms 2 Mycosis Fungoides 2 Meningioma 2 Lymphoma, T-Cell 2 Lymphoma, Large-Cell, Anaplastic 2 Lymphoma 2 Leukemia, Biphenotypic, Acute 2 Histiocytoma, Malignant Fibrous 2 Glioblastoma 2

Interventions

tremelimumab 4 lenvatinib 3 durvalumab 3 Nivolumab 3 Ipilimumab 2 spartalizumab 1 relatlimab 1 poly ICLC 1 pembrolizumab 1 balstilimab 1 Radiotherapy 1 Peptides 1 Opdualag 1 Capecitabine 1 Bevacizumab 1 Axitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡